← Leaderboards
Subbarao Bondada
University Of Kentucky
$10,589,346
Attributed
$13,366,369
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2005–21$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$13,366,369 · 6
By mechanism
R01$7,184,998 · 4
P01$5,778,496 · 1
R21$402,875 · 1
Top collaborators
- D. Allan Butterfield6 shared
- Daret K St Clair6 shared
- Vivek M Rangnekar5 shared
Most similar at University Of Kentucky
Same institution · by research overlap
- D. Allan Butterfield$6,086,051
- Daret K St Clair$20,807,410
- Vivek M Rangnekar$11,055,380
- Ernest Charles Snow$527,235
- Brian M Davis$11,349,901
Others in their field
Top investigators on “Cytokine”
- Sharon L Hillier · Magee-Women'S Hospital Of Upmc$83,965,880
- David Heimbrook · Leidos Biomedical Research, Inc.$56,453,265
- Fulton T Crews · University Of North Carolina Chapel Hill$36,249,590
- Marianne Ward · Duke University$34,872,957
- Joren C Madsen · Massachusetts General Hospital$33,058,731
- Barton F Haynes · Duke University$29,068,807
Research focus
CytokineIn VivoCellsMediatingAnimal ModelIn VitroProteinsApoptoticTherapeutic EffectMacrophageClinical TrialsCancer CellInhibitor/AntagonistCytotoxicChemotherapyTumorLymphomaLaboratory MouseTissue /Cell CultureB LymphocyteFamilyAntibodiesReceptorInflammatory
Grant awards (27)
(PQ9)A redox-mediated mechanism of chemotherapy-induced cognitive impairment$492,343
R01 · FY2021 · CA
(PQ9)A redox-mediated mechanism of chemotherapy-induced cognitive impairment$482,478
R01 · FY2020 · CA
(PQ9)A redox-mediated mechanism of chemotherapy-induced cognitive impairment$458,815
R01 · FY2019 · CA
(PQ9)A redox-mediated mechanism of chemotherapy-induced cognitive impairment$463,899
R01 · FY2018 · CA
(PQ9)A redox-mediated mechanism of chemotherapy-induced cognitive impairment$382,500
R01 · FY2018 · CA
(PQ9)A redox-mediated mechanism of chemotherapy-induced cognitive impairment$455,149
R01 · FY2017 · CA
Role of Tcl1 and Par-4 in regulation of chronic lymphocytic leukemia$381,420
R01 · FY2017 · CA · contact PI
Role of Tcl1 and Par-4 in regulation of chronic lymphocytic leukemia$381,420
R01 · FY2016 · CA · contact PI
Role of Tcl1 and Par-4 in regulation of chronic lymphocytic leukemia$381,420
R01 · FY2015 · CA · contact PI
Role of Tcl1 and Par-4 in regulation of chronic lymphocytic leukemia$369,860
R01 · FY2014 · CA · contact PI
Role of Tcl1 and Par-4 in regulation of chronic lymphocytic leukemia$393,015
R01 · FY2013 · CA · contact PI
Importance of CD5 for the function of regulatory T cells$219,750
R21 · FY2009 · AI · contact PI
Importance of CD5 for the function of regulatory T cells$183,125
R21 · FY2008 · AI · contact PI
Growth Regulation and Therapy of Leukemias and Lymphomas$1,185,331
P01 · FY2007 · CA · contact PI
Growth Regulation and Therapy of Leukemias and Lymphomas$1,185,541
P01 · FY2006 · CA · contact PI
Growth Regulation and Therapy of Leukemias and Lymphomas$1,179,037
P01 · FY2005 · CA
Age Associated Changes in B Lymphocyte Function$289,600
R01 · FY2005 · AG
Growth Regulation and Therapy of Leukemias and Lymphomas$1,144,688
P01 · FY2004 · CA
Age Associated Changes in B Lymphocyte Function$289,600
R01 · FY2004 · AG
Growth Regulation and Therapy of Leukemias and Lymphomas$1,083,899
P01 · FY2003 · CA
Age Associated Changes in B Lymphocyte Function$289,600
R01 · FY2003 · AG
B LYMPHOCYTE RECEPTORS FOR GROWTH AND MATURATION FACTORS$293,444
R01 · FY2002 · AI
Age Associated Changes in B Lymphocyte Function$289,600
R01 · FY2002 · AG
Age Associated Changes in B Lymphocyte Function$289,600
R01 · FY2001 · AG
B LYMPHOCYTE RECEPTORS FOR GROWTH AND MATURATION FACTORS$284,954
R01 · FY2001 · AI
B LYMPHOCYTE RECEPTORS FOR GROWTH AND MATURATION FACTORS$270,715
R01 · FY2000 · AI
AGE ASSOCIATED CHANGES IN B LYMPHOCYTE FUNCTION$245,566
R01 · FY2000 · AG